Treatment of Retinal Vein Occlusion with Ranibizumab in Clinical Practice: Longer-Term Results and Predictive Factors of Functional Outcome

Publisher： Karger

E-ISSN： 1423-0259|55|1|10-18

ISSN： 0030-3747

Source： Ophthalmic Research, Vol.55, Iss.1, 2016-0, pp. : 10-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Outcome after Switching Therapy from Ranibizumab and/or Bevacizumab to Aflibercept in Central Retinal Vein Occlusion

By  

Ophthalmic Research, Vol. 54, Iss. 3, 2015-09 ,pp. : 150-156

Karger

Access to resources Recommend Favorite

Intravitreal Ranibizumab versus Isovolemic Hemodilution in the Treatment of Macular Edema Secondary to Central Retinal Vein Occlusion: Twelve-Month Results of a Prospective, Randomized, Multicenter Trial

By  

Ophthalmologica, Vol. 233, Iss. 1, 2014-12 ,pp. : 8-17

Karger

Access to resources Recommend Favorite

Intravitreal Ranibizumab and Aqueous Humor Factors/Cytokines in Major and Macular Branch Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 235, Iss. 4, 2016-03 ,pp. : 203-207

Karger

Access to resources Recommend Favorite

Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion in a Chinese Population

By  

Ophthalmic Research, Vol. 58, Iss. 1, 2017-03 ,pp. : 8-14

Karger

Access to resources Recommend Favorite

Retinal Vein Occlusion: Current Treatment

By  

Ophthalmologica, Vol. 225, Iss. 3, 2010-04 ,pp. : 135-143

Karger

Access to resources Recommend Favorite